BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 20480786)

  • 1. The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenation.
    Lizzul PF; Narurkar VA
    J Drugs Dermatol; 2010 May; 9(5):446-50. PubMed ID: 20480786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium hydroxylapatite for facial rejuvenation.
    Berlin A; Cohen JL; Goldberg DJ
    Semin Cutan Med Surg; 2006 Sep; 25(3):132-7. PubMed ID: 17055392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable calcium hydroxylapatite microspheres (Radiesse).
    Ridenour B; Kontis TC
    Facial Plast Surg; 2009 May; 25(2):100-5. PubMed ID: 19415577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium hydroxylapatite facial filler (Radiesse): indications, technique, and results.
    Jacovella PF
    Clin Plast Surg; 2006 Oct; 33(4):511-23. PubMed ID: 17085220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium hydroxylapatite (Radiesse) for correction of the mid- and lower face: consensus recommendations.
    Graivier MH; Bass LS; Busso M; Jasin ME; Narins RS; Tzikas TL
    Plast Reconstr Surg; 2007 Nov; 120(6 Suppl):55S-66S. PubMed ID: 18090343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability.
    Silvers SL; Eviatar JA; Echavez MI; Pappas AL
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):34S-45S. PubMed ID: 16936543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-month safety results of calcium hydroxylapatite for treatment of nasolabial folds in Fitzpatrick skin types IV to VI.
    Marmur ES; Taylor SC; Grimes PE; Boyd CM; Porter JP; Yoo JY
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1641-5. PubMed ID: 19708876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of calcium hydroxylapatite (Radiesse) for cosmetic nasolabial fold correction: a meta-analysis and patient centric outcomes study.
    Fakhre GP; Perdikis G; Shaddix KK; Terkonda SP; Waldorf JC
    Ann Plast Surg; 2009 Nov; 63(5):486-9. PubMed ID: 19806045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lasting results with hydroxylapatite (Radiesse) facial filler.
    Jacovella PF; Peiretti CB; Cunille D; Salzamendi M; Schechtel SA
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):15S-21S. PubMed ID: 16936540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation.
    Jansen DA; Graivier MH
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):22S-30S, discussion 31S-33S. PubMed ID: 16936541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimizing discomfort during the injection of Radiesse with the use of either local anesthetic or ice.
    Comite S; Greene A; Cieszynski SA; Zaroovabeli P; Marks K
    Dermatol Online J; 2007 Jul; 13(3):5. PubMed ID: 18328199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds.
    Carruthers A; Liebeskind M; Carruthers J; Forster BB
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S78-84. PubMed ID: 18547186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation.
    Tzikas TL
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S9-15. PubMed ID: 18547188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aesthetic applications of calcium hydroxylapatite volumizing filler: an evidence-based review and discussion of current concepts: (part 1 of 2).
    Emer J; Sundaram H
    J Drugs Dermatol; 2013 Dec; 12(12):1345-54. PubMed ID: 24301235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium hydroxylapatite: Radiesse.
    Ahn MS
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):85-90, vii. PubMed ID: 17317559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face.
    Sadick NS; Katz BE; Roy D
    Dermatol Surg; 2007 Dec; 33 Suppl 2():S122-6; discussion S126-7. PubMed ID: 18086049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of injectable CaHA for the treatment of mid-face volume loss.
    Beer K; Yohn M; Cohen JL
    J Drugs Dermatol; 2008 Apr; 7(4):359-66. PubMed ID: 18459517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-particle calcium hydroxylapatite injection for correction of facial wrinkles and depressions.
    Alam M; Havey J; Pace N; Pongprutthipan M; Yoo S
    J Am Acad Dermatol; 2011 Jul; 65(1):92-6. PubMed ID: 21501888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hand recontouring with calcium hydroxylapatite (Radiesse).
    Edelson KL
    J Cosmet Dermatol; 2009 Mar; 8(1):44-51. PubMed ID: 19250166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial of a novel filler material for soft tissue augmentation of the face containing synthetic calcium hydroxylapatite microspheres.
    Roy D; Sadick N; Mangat D
    Dermatol Surg; 2006 Sep; 32(9):1134-9. PubMed ID: 16970693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.